U.S. Senator Tim Kaine (D-VA) praised the last week’s Senate passage of a bipartisan marijuana research bill he cosponsored.

“This bipartisan bill is going to remove unnecessary barriers that hinder researchers’ ability to study the potential benefits of marijuana-derived medications,” Senator Kaine said as reported by ABC 13 news. “I’m glad it unanimously passed the Senate and is heading to the President to be signed into law.”

What happened – Industry Reactions 

On Wednesday, the Senate passed the Medical Marijuana and Cannabidiol Research Expansion Act, marking the first time that a standalone piece of cannabis reform legislation will reach President Joe Biden’s desk. 

Industry experts praised the move as well. 

“This is the first standalone cannabis reform bill to pass both chambers of congress, which is a major win in itself. This will hopefully coincide with removing cannabis from its senseless Schedule 1 designation," said Bryan Buckley, US Marine Corps veteran and president and CEO of Helmand Valley Growers Company, a cannabis manufacturer that donates 100% of its profits to help veterans. "Cannabis research has been occurring globally for decades, so I’m happy we are finally participating in discovering the potential of this plant. This is just …

Full story available on Benzinga.com